Related Experiment Video
Updated: Jun 29, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Clinical and polysomnographic findings in class III obese patients
Rodrigo de Paiva Tangerina1, Fernanda Louise Martinho, Sonia Maria Togeiro
1Otorhinolaryngology, UNIFESP-EPM. rptangerina@yahoo.com.br
Unlabelled:
The Obstructive Sleep Apnea/Hipopnea Syndrome (OSAHS) is closely related to obesity; a linear relation, however, has not been established, particularly in morbid obesity patients.
Aim:
To evaluate clinical and polysomnographic findings in a group of class III obese patients, and to relate these findings with the presence or absence of OSAHS.
Material And Method:
Forty five patients with body mass index (BMI) over 40Kg/m2 were selected consecutively. A clinical history, the anthropometric examination and polysomnography were undertaken in all patients. The results of a study group and a control group (with no OSAHS) were compared.
Results:
The sample consisted of 68.9% female and 31.1% male patients. The average age was 46.5 years (SD - 10.8 years); the average BMI was 49 (SD - 7 Kg/m2) and the average neck circumference was 43.4 cm (SD - 5.1 cm). All subjects were habitual snorers and 48.9% had daytime drowsiness. Polysomnography showed that 77.8% had an apnea/hipopnea index over 5. The findings associated with OSAHS were: younger age (p=0,02) and an increased neck circumference (p=0.004).
Conclusion:
The prevalence of OSAHS was very high, which emphasizes the importance of investigating this syndrome in patients sent for bariatric surgery. The neck circumference was the best OSAHS marked in this group of patients.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Type I Diabetes III: Clinical Manifestations
Management of Insomnia
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Drug Dosing: Obese Patients
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

